Vascular mechanisms of renal fibrosis. Vasculonephropathies and hypertension;Mécanismes vasculaires de la fibrose rénale. Néphrovasculopathies et hypertension artérielle

Bulletin de l'Academie Nationale de Medecine

Volumn 183, Issue 1, 1999, Pages 33-46

  Meyrier, Alain ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; FIBROSIS; HUMAN; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY; RENOVASCULAR HYPERTENSION; REVIEW;

FIBROSIS; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY; KIDNEY FAILURE, CHRONIC;

EID: 0033423861     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. FAHR T. - Über Nephrosklerose. Virchows Arch (Pathol Anat), 1919, 26, 119-178.
2. VOLHARD F. - D. Die Sklerosen. Die doppelseitigen hämatogenen Nierenerkrankungen (Brightsche Krankheit). Berlin: Verlag J. Springer, 1918, D. Die Sklerosen. p. 491.
3. CAMERON J.S., HICKS J. - Frederick Akbar Mahomed and his role in the description of hypertension at Guy's Hospital. Kidney Int., 1996, 49, 1488-1506.
4. MEYRIER A., SIMON P. - Nephroangiosclerosis and hypertension: things are not as simple as you might think. Nephrol Dial Transpl., 1996, 11, 2116-2120.
5. MARKS L.S., MAXWELL M.H. - Tigerstedt and the discovery of renin: an historical note. Hypertension, 1979, 1, 384-388.
6. GOLDBLATT H., LYNCH J., HANZAL R.F., SUMMERVILLE W.W. Studies on experimental hypertension. 1. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exper Med., 1934, 59, 347-379.
7. ROBERTSON J.I.S. - Renin and angiotensin: a historical review. In: Robertson JIS, Nicholls MG, ed. The Renin-Angiotensin System. London, New York: Gower Medical Publishing, 1993, pp 1.1-1.18.
8. ARDAILLOU R., CHANSEL D. Synthesis and effects of active fragments of angiotensin II. Kidney Int., 1997, 52, 1458-1468.
9. KINCAID-SMITH P. - Vascular lesions associated with idiopathic glomerular lesions. In: Kincaid-Smith P, ed. The Kidney. A Clinico-Pathological Study. Oxford: Blackwell Scientific Publications, 1975, pp 193-202.
10. POUTASSE E.F., HUMPHRIES A.W., MCCORMACK L.J., CORCORAN A.C. - Bilateral stenosis of renal arteries and hypertension. Treatment by arterial homografts. JAMA, 1956, 161, 419-423.
11. JACOBSON H.R. - Ischemic renal disease: An overlooked clinical entity? Kidney Int., 1988, 34, 729-743.
12. ABUELO J.G. - Diagnosing vascular causes of renal failure. Ann Intern Med., 1995, 123, 601-614.
13. MEYRIER A., CALLARD P. - La biopsie rénale dans les néphroangioscléroses et la sclérodermie. In: Droz D, Lantz B, ed. La biopsie rénale. Paris: INSERM, 1996, pp 353-363.
14. HELMCHEN U., WENZEL U.O. - Benign and malignant nephrosclerosis and renovascular disease. In: Tisher CC, Brenner BM, ed. Renal Pathology. 2nd, Philadelphia: J.B. Lippincott Company, 1994, pp 1201-1236.
15. MEYRIER A., LAABAN J.P., KANFER A. - Protracted anuria due to active renal vasoconstriction in malignant hypertension. Br Med J., 1984, 288, 1045-1046.
16. TRACY R.E., VELEZ-DURAN M., HEIGLE T., OALMANN M.C. - Two variants of nephrosclerosis separately related to age and blood pressure. Am J Pathol., 1988, 131, 270-282.
17. RUILOPE L.M., ALCAZAR J.M., RODICIO J.L. - Renal consequences of arterial hypertension. J Hypertens., 1992, (Suppl 10), S85-S90.
18. MEYRIER A., SIMON P., MONTSENY J.J., ELADARI D., CHARASSE C. - Néphropathies artérielles et néphroangiosclérose. Epidémiologie et physiopathologie. In: Funck-Brentano JL, Bach JF, Kreis H, Grünfeld JP, ed. Actualités Néphrologiques - Jean Hamburger, Hôpital Necker. Paris: Flammarion Médecine-Sciences, 1996, pp 145-183.
19. MEYRIER A., HILL G.S., SIMON P. - Ischemic renal diseases: New insights into old entities. Kidney Int., 1998, 54, 2-13.
20. FOGO A., BREYER J.A., SMITH M.C., CLEVELAND W.H., AGODOA L., KIRK K.A., GLASSOCK R., and the AASK pilot study investigators - Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report of the African American Study of Kidney Disease (AASK) trial. Kidney Int., 1997, 51, 244-252.
21. QUALHEIM R.E., ROSTAND S.G., KIRK K.A., RUTSKY E.A., LUKE R.G. - Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis., 1991, 18, 336-343.
22. WEISSTUCH J.M., DWORKIN L.D. - Does essential hypertension cause end-stage renal disease? Kidney Int., 1992, 41, 33-37.
23. TRACY R.E., GUZMAN M.A., OALMANN M.C, NEWMAN W.P, STRONG J.P. - Nephrosclerosis in three cohorts of Black and White men born 1925 to 1944, 1934 to 1953 and 1943 to 1962. Am J Hypertens., 1993, 6, 185-192.
24. TRACY R.E. - Renovasculopathies of hypertension and the rise of blood pressure with age in blacks and whites. Semin Nephrol., 1996, 16, 126-133.
25. FELD L.G., VAN LIEW J.B., BRENTJENS J.R., BOYLAN J.W., BEMBEN S., CHANG H., MANZ N. -Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kidney Int., 1981, 20, 606-614.
26. SMEDA J.S., LEE R.M., FORREST J.B. - Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. Circ Res., 1988, 63, 534-542.
27. KREGE J.H., JOHN S.W.M., LANGENBACH L.L., HODGIN J.B., HAGAMAN J.R., BACHMAN E.S., JENNETTE J.C., O'BRIEN D.A., SMITHIES O. - Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature, 1995, 375, 146-148.
28. KIM H.S., KREGE J.H., KLUCKMAN K.D., HAGAMAN J.R., HODGIN J.B., BEST C.F., JENNETTE J.C., COFFMAN T.M., MAEDA N., SMITHIES O. - Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA., 1995, 92, 2735-2739.
29. HOCHER B., THÖNE-REINEKE C., ROHMEISS P., SCHMAGER F., SLOWINSKI T., BURST V., SIEGMUND F., QUERTERMOUS T., BAUER C., NEUMAYER H.H., SCHLEUNING W.D., THEURING F. -Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest., 1997, 99, 1380-1389.
30. FERNANDEZ-LLAMA P., POCH E., ORIOLA J., BOTEY A., COLL E., DARNELL A., RIVERA F., REVERT L. - Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int., 1998, 53, 1743-1747.
31. HRICIK D.E., BROWNING P.J., KOPELMAN R., GOORNO W.E., MADIAS N.E., DZAU V.J. -Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med., 1983, 308, 373-376.
32. NOVICK A.C., TEXTOR S.C., BODIE B., KHAULI R.B. - Revascularization to preserve renal function in patients with atherosclerotic renovascular disease. Urol Clin North Am., 1984, 11, 477-490.
33. SCOBLE J.E., HAMILTON G. - Atherosclerotic renovascular disease: remediable cause of renal failure in the elderly. Br Med J., 1990, 300, 1670-1671.
34. CONLON P.J., ATHIRAKUL K., KOVALIK E., SCHWAB S.J., CROWLEY J., STACK R., MCCANTS C.B.J., MARK D.B., BASHORE T.M., ALBERS F. - Survival in renal vascular disease. J Am Soc Nephrol., 1998, 9, 252-256.
35. GRECO B.A., BREYER J.A. - Atherosclerotic ischemic renal disease. Am J Kidney Dis., 1997, 29, 167-187.
36. PLOUIN P.F., JEUNEMAITRE X., CHATELLIER G., JULIEN J., RAYNAUD A. - Intérêts et limites de l'exploration des artères rénales chez les hypertendus âgés. Néphrologie, 1990, 11, 297-299.
37. VETROVEC G.W., LANDWEHR D.M., EDWARDS V.L. - Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography. J Interven Cardiol., 1989, 2, 69-76.
38. HARDING M.B., SMITH L.R., HIMMELSTEIN S.I., HARRISON K., PHILLIPS H.R., SCHWAB S.J., HERMILLER J.B., DAVIDSON C.J., BASHORE T.M. - Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol., 1992, 2, 1608-1616.
39. RAMIREZ G., BUGNI W., FARBER S.M., CURRY A.J. - Incidence of renal artery stenosis in a population having cardiac catheterization. South Med J., 1987, 80, 734-737.
40. OLIN J.W, PIEDMONTE M.R., YOUNG J.R., DEANNA S., GRUBB M., CHILDS M.B. - The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med., 1995, 122, 833-838.
41. APPEL R.G., BLEYER A.J., REAVIS S., HANSEN K.J. - Renovascular disease in older patients beginning renal replacement therapy. Kidney Int., 1995, 48, 171-176.
42. TEXTOR S.C., MCKUSICK M.A., SCHIRGER A.A., BONELLI F.S., HALLETT J.W. - Maladie rénovasculaire par athérosclérose chez les insuffisants rénaux. In: Grünfeld JP, Bach JF, Kreis H, ed. Actualités Néphrologiques - Jean Hamburger. Paris: Flammarion Médecine-Sciences, 1997, pp 271-282.
43. SCHREIBER M.J., POHL M.A., NOVICK A.C. - The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am., 1984, 11, 383-391.
44. NOVICK A.C., POHL M.A., SCHREIBER M., GIFFORD R.W., VIDT D.G. - Revascularization for preservation of renal function in patients with atherosclerotic renovascular disease. J Urol., 1983, 129, 907-912.
45. KAYLOR W.M., NOVICK A.C., ZIBGELBAUM M. - Reversal of end stage renal failure with surgical revascularization in patients with atherosclerotic renal artery occlusion. J Urol., 1989, 141, 486-488.
46. TEXTUR S.C. - Revascularization in atherosclerotic renal artery disease. Kidney Int., 1998, 53, 799-811.
47. TEXTOR S.C. - Pathophysiology of renal failure in renovascular disease. Am J Kidney Dis., 1994, 24, 642-651.
48. CAPS M.T., ZIERLER R.E., POLISSAR N.L., BERGELIN R.O., BEACH K.W., CANTWELL-GAB K., CASADEI A., DAVIDSON R.C., STRANDNESS D.E., JR. - Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int., 1998, 53, 735-742.
49. MORAN K., MULHALL J., KELLY D., SHEEHAN S., DOWSETT J., DERVAN P., FITZPATRICK: J.M. -Morphological changes and alterations in regional intrarenal blood flow induced by graded renal ischemia. J Urol., 1992, 148, 463-466.
50. BRIDOUX F., HAZZAN M., PALLOT J.L., FLEURY D., LEMAITRE V., KLEINKNECHT D., VANHILLE P. Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis. Nephrol Dial Transpl., 1992, 7, 100-104.
51. SHANLEY P.F. The pathology of chronic renal ischemia. Semin Nephrol., 1996, 16, 21-32.
52. GOBÉ G.C., AXELSEN R.A., SEARLE J.W. - Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest., 1990, 63, 770-779.
53. RIMMER J.M., GENNARI J. - Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med., 1993, 118, 712-719.
54. BONELLI F.S., MCKUSICK M.A., TEXTOR S.C., KOS P.B., STANSON A.W., JOHNSON C.M., SHEEDY P.F.I., WELCH T.J., SCHIRGER A. - Renal artery angioplasty: Technical results and clinical outcome in 320patients. Mayo Clin Proc., 1995, 70, 1041-1052.
55. ANDOH T.F., BENNETT W.M. - Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens., 1998, 7, 265-270.
56. BOHLE A., MÜLLER G.A., WEHRMANN M., MACKENSEN-HAEN S., XIAO J.-C. - Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic intertsitial nephritides. Kidney Int., 1996, 49, Suppl 54, S-2-S-9.
57. BORDER W.A., NOBLE N.A. - Interactions of TGF-β and angiotensin II in renal fibrosis. Hypertension, 1998, S31, 181-188.
58. JOHNSON R.J., ALPERS C.E., YOSHIMURA A., LOMBARDI D., PRITZL P., FLOEGE J., SCHWARTZ S.M. Renal injury from angiotensin II - mediated hypertension. Hypertension, 1992, 19, 464-474.
59. EDDY A.A. - Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol., 1996, 7, 2495-2508.
60. PETERS H., BORDER W.A., NOBLE N.A. - Targeting TGF-β overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int., 1998, 54, 1570-1580.
61. MEYRIER A., BUCHET P., SIMON P., FERNET M., RAINFRAY M., CALLARD P. - Atheromatous renal disease. Am J Med., 1988, 85, 139-146.
62. FINE M.J., KAPOOR W., FALANGA V. - Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology, 1987, 38, 769-784.
63. THADHANI R.I., CAMARGO C.A., JR, XAVIER R.J., FANG L.S., BAZARI H. - Atheroembolic renal failure after invasive procedures: Natural history based on 52 histologically proven cases. Medicine, 1995, 74, 350-358.
64. BELENFANT X., MEYRIER A., JACQUOT C. - Specific treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis., accepté pour publication, 1999
65. BARIETY J., NOCHY D., JACQUOT C., MANDET C., CALLARD P., MEYRIER A. - Diversité et unité des hyalinoses segmentaires et focales des glomérules. In: Grünfeld JP, Bach JF, Kreis H, ed. Actualités Néphrologiques - Jean Hamburger. Paris: Flammarion Médecine-Sciences, 1998, pp 1-33
66. PERERA G. - Hypertensive vascular disease: Description and natural history. J Chronic Dis., 1955, 1, 33-42.
67. ZUCCHELLI P., ZUCCALA A. - The diagnostic dilemma of hypertensive nephrosclerosis: The nephrologist's view. Am J Kidney Dis., 1993, 21, 87-91.
68. KLAG M.J., WHELTON P.K., RANDALL B.L., NEATON J.D., BRANCATI F.L., FORD C.E., SHULMAN N.B., STAMLER J. - Blood pressure and end-stage renal disease in men. N Engl J Med., 1996, 334, 13-18.
69. TOTO R.D., MITCHELL H.C., SMITH R.D., LEE H.C., MCINTIRE D., PETTINGER W.A. - «Strict» blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int., 1995, 48, 851-859.
70. TOTO R.D., MITCHELL H.C., PETTINGER W.A. Treatment of hypertension in nondiabetic renal disease. Curr Opin Nephrol Hypertens., 1994, 3, 279-285.
71. MASCHIO G., ALBERTI D., JANIN G., LOCATELLI F., MANN J.F.E., MOTOLESE M., PONTICELLI C., RITZ E., ZUCCHELLI P., ANGIOTENSIN-CONVERTING-ENZYME INHIBITION IN PROGRESSIVE RENAL INSUFFICIENCY STUDY GROUP - Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med., 1996, 334, 939-945.